REFERENCES
  1. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.Int J Cancer . 2019;144(8):1941-1953.
  2. European association U [European Association of Urology guidelines]. Edition. Vol. presented at the EAU Annual Congress Amsterdam; 2020. Arnhem, The Netherlands: European Association of Urology Guidelines Office:2020.
  3. Reisæter LA, Fütterer JJ, Halvorsen OJ, et al. 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy.Acta radiol . 2015;56(4):500-511.
  4. Hoeks CM, Hambrock T, Yakar D, et al. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.Radiology . 2013;266(1):207-217.
  5. Eiber M, Weirich G, Holzapfel K, et al. Simultaneous 68Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer.Eur Urol . 2016;70(5):829-836.
  6. Hoffmann MA, Wieler HJ, Baues C, Kuntz NJ, Richardsen I, Schreckenberger M. The impact of 68Ga-PSMA PET/CT and PET/MRI on the management of prostate cancer. Urology . 2019;130:1-12.
  7. Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS Prostate Imaging–Reporting and Data System ; 2015, version 2. European urology. 2016; vol 69(1):16-40.
  8. Epstein JI, Egevad L, Amin MB, et al. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol . 2016;40(2):244-252.
  9. Perera M, Lawrentschuk N, Bolton D, Clouston D. Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens. BJU Int . 2014;113(suppl 2):29-34.
  10. Arora R, Koch MO, Eble JN, et al. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer: interdisciplinary.Int J Am Cancer Society. 2004;100(11):2362-2366.
  11. de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM. Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol . 2016;70(2):233-245.
  12. Drost FH, Osses DF, Nieboer D, et al. Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev . 2019;4:CD012663.
  13. Le JD, Tan N, Shkolyar E, et al. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol . 2015;67(3):569-576.
  14. Hartenbach M, Hartenbach S, Bechtloff W, et al. Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: a prospective diagnostic trial. Clin Cancer Res . 2014;20(12):3244-3253.
  15. Al-Bayati M, Grueneisen J, Lütje S, et al. Integrated 68gallium labelled prostate-specific membrane antigen-11 positron emission tomography/magnetic resonance imaging enhances discriminatory power of multi-parametric prostate magnetic resonance imaging. Urol Int . 2018;100(2):164-171.
  16. de Perrot T, Rager O, Scheffler M, et al. Potential of hybrid 18 F-fluorocholine PET/MRI for prostate cancer imaging. Eur J Nucl Med Mol Imaging . 2014;41(9):1744-1755.
  17. Lee MS, Cho JY, Kim SY, et al. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: comparative study of multiparametric MRI and PET/CT. J Magn Reson Imaging . 2017;45(2):597-609.
  18. Hicks RM, Simko JP, Westphalen AC, et al. Diagnostic accuracy of 68Ga-PSMA-11 PET/MRI compared with multiparametric MRI in the detection of prostate cancer. Radiology . 2018;289(3):730-737.
  19. Jambor I, Kuisma A, Kähkönen E, et al. Prospective evaluation of 18 F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate-to high-risk prostate cancer patients (FLUCIPRO trial).Eur J Nucl Med Mol Imaging . 2018;45(3):355-364.
  20. Park SY, Zacharias C, Harrison C, et al. Gallium 68 PSMA-11 PET/MR imaging in patients with intermediate- or high-risk prostate cancer.Radiology . 2018;288(2):495-505.
  21. Li M, Huang Z, Yu H, Wang Y, Zhang Y, Song B. Comparison of PET/MRI with multiparametric MRI in diagnosis of primary prostate cancer: A meta-analysis. Eur J Rad . 2019;113:225-231.